(Press-News.org) PORTLAND, Ore. – A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol – drugs that offer them no benefit and may increase other health risks such as diabetes, dementia or muscle pain.
The findings, which were published in the American Journal of Cardiovascular Drugs as a review of multiple studies, raise serious questions about the value of cholesterol-lowering therapies in kidney disease.
The issue is important, the researchers say, because the incidence of chronic kidney disease is rising in the United States at what they called "an alarming rate." Also, kidney disease patients are 23 times more likely to get cardiovascular disease, and for them it's the leading cause of death.
But for these patients, the frequent decision to prescribe statin drugs to lower cholesterol in order to reduce the risk of cardiovascular disease is not supported by the wider body of research, experts say.
"There is very little benefit to statin drugs for patients in the early stages of kidney disease, and no benefit or possible toxicity for patients in later stages," said Ali Olyaei, a professor of pharmacotherapy in the College of Pharmacy at Oregon State University, and lead author on the new report.
"I believe the evidence shows that the majority of people with chronic kidney disease are taking statins inappropriately," Olyaei said. "They may help a little in early-stage disease, but those people are not the ones who generally die from cardiovascular diseases. And by the end stages the risks outweigh any benefit. More drugs are not always better."
Some of the particular risks posed by statin use, especially at higher doses, include severe muscle pain known as rhabdomyolysis, an increase in dementia and a significant increase in the risk of developing diabetes. The body of research also shows that statins do nothing to slow the progression of kidney disease, contrary to some reports that it might.
The impetus to use statin drugs – some of the most widely prescribed medications in the world to lower cholesterol – is obvious in end-stage kidney disease, because those patients have a mortality rate from coronary heart disease 15 times that of the general population. Unfortunately, evidence shows the drugs do not help prevent mortality in that situation. There is also no proven efficacy of the value of statins in patients using dialysis, researchers said.
If statins are prescribed in early-stage kidney disease, the study concluded that low dosages are more appropriate.
###
Collaborators on this report, which was supported by OSU, included researchers from the Oregon Health and Science University and the University of Illinois at Chicago.
Editor's Note: The study this story is based on is available online: http://bit.ly/17EPkHd
Statins being overprescribed for growing number of kidney disease patients
2013-09-10
ELSE PRESS RELEASES FROM THIS DATE:
New report reviews science and engineering quality at national security laboratories
2013-09-10
WASHINGTON — The science and engineering capabilities that underpin the nuclear weapons stockpile stewardship and nonproliferation missions at the nation's three national security laboratories are "healthy and vibrant," says a new report from the National Research Council. The committee that wrote the report found no problems with the quality of science and engineering that would prevent certification of the stockpile. However, the report identifies several issues that, if not addressed, have the potential to erode the ability to perform high-quality work at the laboratories. ...
US faces crisis in cancer care, says new IOM report
2013-09-10
WASHINGTON -- Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors -- a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine. The report recommends ways to respond to these challenges and improve cancer care delivery, including by strengthening clinicians' core competencies in caring for patients with cancer, shifting to team-based models of care, and communicating more effectively with patients. ...
Teens interested in healthy minds -- and ripped bodies
2013-09-10
This news release is available in French. Montreal, September 10, 2013 — Dreams of washboard abs and toned arms may seem to be the main motivation for the average teen to lace up their running shoes. But over 1,000 Montreal high school students disagree. Teens, it seems, are smarter than their parents when it comes to approaching exercise as something that affects one's whole body.
In a recent study on adolescent perceptions surrounding physical activity, James Gavin, professor in Concordia University's Department of Applied Human Sciences, found that teens are just ...
Study: Redefining the criteria for ALK positive lung cancer
2013-09-10
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.
ALK stands for anaplastic lymphoma kinase, a gene that is turned off in most adult tissues in the body, but which can be re-activated ...
Study suggests possibility of selectively erasing unwanted memories
2013-09-10
JUPITER, FL, September 10, 2013 – The human brain is exquisitely adept at linking seemingly random details into a cohesive memory that can trigger myriad associations—some good, some not so good. For recovering addicts and individuals suffering from post-traumatic stress disorder (PTSD), unwanted memories can be devastating. Former meth addicts, for instance, report intense drug cravings triggered by associations with cigarettes, money, even gum (used to relieve dry mouth), pushing them back into the addiction they so desperately want to leave.
Now, for the first time, ...
The chemistry behind the character of bourbon, scotch and rye
2013-09-10
Contact: Michael Bernstein
m_bernstein@acs.org
317-262-5907 (Indianapolis Press Center, Sept. 6-11)
202-872-6042
Michael Woods
m_woods@acs.org
317-262-5907 (Indianapolis Press Center, Sept. 6-11)
202-872-6293
American Chemical Society
The chemistry behind the character of bourbon, scotch and rye
INDIANAPOLIS, Sept. 9, 2013 — Whiskeys have long captivated the senses of connoisseurs, whether with smokiness and a whiff of vanilla or a spicy character with hints of caramel, and now, the emerging chemistry of "brown spirits" is proving that they have ...
September/October 2013 Annals of Family Medicine Tip Sheet
2013-09-10
One-third of Walgreens Vaccinations Are Administered During Off-Clinic Hours, Implications for Improving Vaccination Access and Convenience
With adult and adolescent vaccination rates below national goals, this study of more than six million vaccinations administered in more than 7,500 Walgreens pharmacies across the United States identifies a potentially important public health impact pharmacies can make by providing vaccines during convenient times that expand access to particular groups of people. Analyzing data on 6,250,402 vaccines administered at the pharmacy chain ...
Chemists develop new approaches to understanding disturbing trends near Earth's surface
2013-09-10
Contact: Rachael Bishop
r_bishop@acs.org
434-996-6246 (Indianapolis Press Center, Sept. 7-11)
202-872-4445
Michael Woods
m_woods@acs.org
317-262-5907 (Indianapolis Press Center, Sept. 6-11)
202-872-6293
American Chemical Society
Chemists develop new approaches to understanding disturbing trends near Earth's surface
INDIANAPOLIS, Sept. 9, 2013 — Chemists who are members of the American Chemical Society (ACS), collaborating with scientists from other fields through the University of California, San Diego (UCSD) Center for Aerosol Impacts on Climate and the ...
Closing in on risk factors for cerebral palsy and infant death
2013-09-10
Karin B. Nelson, M.D., scientist emeritus at the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and her colleagues from the University of Sydney, the University of Western Australia and Sydney Adventist Hospital in Australia examined the degree to which four specific risk factors contributed to cerebral palsy and young infant death. The risk factors were asphyxial birth events (incidences during labor and delivery that had the potential to interfere with oxygen getting to the newborn's brain), inflammation (signs ...
New report finds no evidence that safety-net patients receive substandard primary care
2013-09-10
WASHINGTON and NEW YORK—A new study by researchers at the George Washington University School of Public Health and Health Services (SPHHS) finds no evidence that primary care physicians provide "second-class" care to Medicaid, uninsured and other patients who rely on the nation's safety-net system. The study, which appears in the September issue of the journal Health Affairs, challenges previous claims that the care provided to low-income and vulnerable patients is substandard. The new study was supported by the Geiger/Gibson RCHN Community Health Foundation Research Collaborative.
"The ...